What is Hemophilia?

Hemophilia is an inherited disorder that affects the blood’s clotting capacity. Normally, when a person cuts themselves, clotting factors in the blood bind with platelets and blood cells to make it sticky, which eventually prevents bleeding.

Platelets are very important in the blood clotting process because their sticky surfaces help them bind together and stop bloodflow. The clotting factors then from a mesh around the platelets to hold them in place. In hemophilia, however, a deficiency in these clotting factors means bleeding continues for a longer period than usual.

Types of hemophilia

Hemophilia is categorized according to which clotting factor is deficient. In hemophilia A, clotting factor VIII is deficient and in hemophilia B, clotting factor IX is deficient. Most cases of hemophilia are hemophilia A.


The symptoms of hemophilia range from mild to severe depending on the level of clotting factors present in the blood. In most cases, the condition is severe and people are at risk of internal bleeding. This causes pain and stiffness in the joints and muscles, which can eventually become permanently damaged.

Who is affected?

The inheritance pattern of hemophilia means that mainly males are affected by this condition. Estimates show that around one boy in every 5,000 is born with hemophilia A and around 1 in every 30,000 is born with haemophilia B. Females who carry the haemophilia gene may also experience problems with bleeding such as heavy periods.

Diagnosis and treatment

Diagnosis is confirmed by blood tests to check whether the blood is clotting properly. The platelet count, prothrombin time (PT) and activated partial thromboplastin time (aPTT) are checked. If the platelet count and PT are normal but the aPPT is prolonged, hemophilia is indicated. Specific tests to check the clotting factor levels can then be carried out to confirm a diagnosis.

Hemophilia cannot be cured but people with the illness can manage their condition using medication and still enjoy a good quality of life. Genetically engineered clotting factor medications are now routinely administered to prevent and treat prolonged bleeding.

Further Reading

Last Updated: Feb 26, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, February 26). What is Hemophilia?. News-Medical. Retrieved on December 02, 2021 from https://www.news-medical.net/health/What-is-Hemophilia.aspx.

  • MLA

    Mandal, Ananya. "What is Hemophilia?". News-Medical. 02 December 2021. <https://www.news-medical.net/health/What-is-Hemophilia.aspx>.

  • Chicago

    Mandal, Ananya. "What is Hemophilia?". News-Medical. https://www.news-medical.net/health/What-is-Hemophilia.aspx. (accessed December 02, 2021).

  • Harvard

    Mandal, Ananya. 2019. What is Hemophilia?. News-Medical, viewed 02 December 2021, https://www.news-medical.net/health/What-is-Hemophilia.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.